Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
Roger S ZouYunfeng RuanBuu TruongRomit BhattacharyaMichael T LuJúlia KarádyRachel BernardoPhoebe FinneranWhitney E HornsbyKathleen V FitchHeather J RibaudoMarkella V ZanniPamela S DouglasSteven K GrinspoonAniruddh Pradip PatelPradeep NatarajanPublished in: Journal of the American Heart Association (2024)
URL: https://www.reprievetrial.org; Unique identifier: NCT02344290.
Keyphrases
- cardiovascular disease
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- phase iii
- hepatitis c virus
- study protocol
- hiv aids
- clinical trial
- men who have sex with men
- phase ii
- cell therapy
- cardiovascular events
- cardiovascular risk factors
- south africa
- randomized controlled trial
- stem cells
- coronary artery disease
- mesenchymal stem cells